Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 5 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar portefeuille (99.66) Submitted: 12/18/2012 10:53:54 PM : Outperform Start Price: $7.48 THLD Score: -67.90

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement